|
| SRC/ABL inhibition disrupts CRLF2driven signaling to induce cell death in Bcell acute lymphoblastic leukemia |
|
https://doi.org/10.18632/oncotarget.25089
Jolanda Sarno, Angela M. Savino, Chiara Buracchi, Chiara Palmi, Stefania Pinto, Cristina Bugarin, Astraea Jager, Silvia Bresolin, Ruth C. Barber, Daniela Silvestri, Shai Israeli, Martin J.S. Dyer, Giovanni Cazzaniga, Garry P. Nolan, Andrea Biondi, Kara L. Davis, and Giuseppe Gaipa
|
| 22872-22885 |
|
| Analysis of KIT gene mutations in patients with melanoma of the head and neck mucosa: a retrospective clinical report |
|
https://doi.org/10.18632/oncotarget.25094
Ullyanov Bezerra Toscano de Mendonça, Claudio Roberto Cernea, Leandro Luongo Matos, and Roberto Rego Monteiro de Araujo Lima
|
| 22886-22894 |
|
| Comprehensive molecular analysis based on somatic copy number alterations in intramucosal colorectal neoplasias and early invasive colorectal cancers |
|
https://doi.org/10.18632/oncotarget.25112
Tamotsu Sugai, Makoto Eizuka, Wataru Habano, Yasuko Fujita, Ayaka Sato, Ryo Sugimoto, Kouki Otsuka, Eiichiro Yamamoto, Takayuki Matsumoto, and Hiromu Suzuki
|
| 22895-22906 |
|
| Involvement of SNPs in miR3117 and miR3689d2 in childhood acute lymphoblastic leukemia risk |
|
https://doi.org/10.18632/oncotarget.25144
Angela Gutierrez-Camino, Idoia Martin-Guerrero, Vita Dolza, Janez Jazbec, Ana Carbone-Bañeres, Nagore Garcia de Andoin, Ana Sastre, Itziar Astigarraga, Aurora Navajas, and Africa Garcia-Orad
|
| 22907-22914 |
|
| YdjC chitooligosaccharide deacetylase homolog induces keratin reorganization in lung cancer cells: involvement of interaction between YDJC and CDC16 |
|
https://doi.org/10.18632/oncotarget.25145
Eun Ji Kim, Mi Kyung Park, Hyun Jung Byun, Gyeoung Jin Kang, Lu Yu, Hyun Ji Kim, Jae Gal Shim, Ho Lee, and Chang Hoon Lee
|
| 22915-22928 |
|
| Disturbed alternative splicing of FIR PUF60 directed cyclin E overexpression in esophageal cancers |
|
https://doi.org/10.18632/oncotarget.25149
Yukiko Ogura, Tyuji Hoshino, Nobuko Tanaka, Guzhanuer Ailiken, Sohei Kobayashi, Kouichi Kitamura, Bahityar Rahmutulla, Masayuki Kano, Kentarou Murakami, Yasunori Akutsu, Fumio Nomura, Sakae Itoga, Hisahiro Matsubara, and Kazuyuki Matsushita
|
| 22929-22944 |
|
| Using antibody directed phototherapy to target oesophageal adenocarcinoma with heterogeneous HER2 expression |
|
https://doi.org/10.18632/oncotarget.25159
Hayley Pye, Mohammed Adil Butt, Laura Funnell, Halla W. Reinert, Ignazio Puccio, Saif U. Rehman Khan, Savvas Saouros, Jared S. Marklew, Ioanna Stamati, Maryam Qurashi, Rehan Haidry, Vinay Sehgal, Dahmane Oukrif, Michael Gandy, Hayley C. Whitaker, Manuel Rodriguez-Justo, Marco Novelli, Rifat Hamoudi, Gokhan Yahioglu, Mahendra P. Deonarain, and Laurence B. Lovat
|
| 22945-22959 |
|
| Preclinical evaluation of a GFRA1 targeted antibodydrug conjugate in breast cancer |
|
https://doi.org/10.18632/oncotarget.25160
Emily E. Bosco, R. James Christie, Rosa Carrasco, Darrin Sabol, Jiping Zha, Karma DaCosta, Lee Brown, Maureen Kennedy, John Meekin, Sandrina Phipps, Joanne Ayriss, Qun Du, Binyam Bezabeh, Partha Chowdhury, Shannon Breen, Cui Chen, Molly Reed, MaryJane Hinrichs, Haihong Zhong, Zhan Xiao, Rakesh Dixit, Ronald Herbst, and David A. Tice
|
| 22960-22975 |
|
| Carbon ion radiotherapy for inoperable pediatric osteosarcoma |
|
https://doi.org/10.18632/oncotarget.25165
Osama Mohamad, Reiko Imai, Tadashi Kamada, Yuki Nitta, Nobuhito Araki, and the Working Group for Bone and Soft Tissue Sarcoma
|
| 22976-22985 |
|
| Combination of two antitubulin agents eribulin and paclitaxel enhances antitumor effects on triplenegative breast cancer through mesenchymalepithelial transition |
|
https://doi.org/10.18632/oncotarget.25184
Takaaki Oba, and Ken-Ichi Ito
|
| 22986-23002 |
|
| Bromodomain protein BRD4 inhibitor JQ1 regulates potential prognostic molecules in advanced renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.25190
Takashi Sakaguchi, Hirofumi Yoshino, Satoshi Sugita, Kazutaka Miyamoto, Masaya Yonemori, Yoichi Osako, Makiko Meguro-Horike, Shin-ichi Horike, Masayuki Nakagawa, and Hideki Enokida
|
| 23003-23017 |
|
| Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST |
|
https://doi.org/10.18632/oncotarget.25195
Hsiang-Chih Lu, Vanessa Eulo, Anthony J. Apicelli, Melike Pekmezci, Yu Tao, Jingqin Luo, Angela C. Hirbe, and Sonika Dahiya
|
| 23018-23028 |
|
| Targeting the spliceosome for cutaneous squamous cell carcinoma therapy: a role for cMYC and wildtype p53 in determining the degree of tumour selectivity |
|
https://doi.org/10.18632/oncotarget.25196
Lydia A. Hepburn, Angela McHugh, Kenneth Fernandes, Garry Boag, Charlotte M. Proby, Irene M. Leigh, and Mark K. Saville
|
| 23029-23046 |
|
| Riskstratified surveillance protocol improves costeffectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma |
|
https://doi.org/10.18632/oncotarget.25198
Masaki Momota, Shingo Hatakeyama, Hayato Yamamoto, Hiromichi Iwamura, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi, and Chikara Ohyama
|
| 23047-23057 |
|
| Oncodriver inhibition and CD4+ Th1 cytokines cooperate through Stat1 activation to induce tumor senescence and apoptosis in HER2+ and triple negative breast cancer: implications for combining immune and targeted therapies |
|
https://doi.org/10.18632/oncotarget.25208
Cinthia Rosemblit, Jashodeep Datta, Lea Lowenfeld, Shuwen Xu, Amrita Basu, Krithika Kodumudi, Doris Wiener, and Brian J. Czerniecki
|
| 23058-23077 |
|
| Metabolomics based predictive classifier for early detection of pancreatic ductal adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.25212
Keith Unger, Khyati Y. Mehta, Prabhjit Kaur, Yiwen Wang, Smrithi S. Menon, Shreyans K. Jain, Rose A. Moonjelly, Shubhankar Suman, Kamal Datta, Rajbir Singh, Paul Fogel, and Amrita K. Cheema
|
| 23078-23090 |
|
| Abundance of TRAIL attenuated by HIF2α and cFLIP affects malignancy in renal cell carcinomas |
|
https://doi.org/10.18632/oncotarget.25214
Takahiro Isono, Tokuhiro Chano, Tetsuya Yoshida, Susumu Kageyama, Akihiro Kawauchi, Junji Yonese, and Takeshi Yuasa
|
| 23091-23101 |
|
| A targeted transforming growth factorbeta TGFβ blocker TTB inhibits tumor growth and metastasis |
|
https://doi.org/10.18632/oncotarget.24562
Changhua Zhou, Jing Li, Limin Lin, Rui Shu, Bin Dong, Donglin Cao, Qing Li, and Zhong Wang
|
| 23102-23113 |
|
| Association of increased primary breast tumor AGR2 with decreased diseasespecific survival |
|
https://doi.org/10.18632/oncotarget.25225
Phoebe Ann, Brandon-Luke L. Seagle, Arunima Shilpi, Manoj Kandpal, and Shohreh Shahabi
|
| 23114-23125 |
|
| Differential prognostic impact of interleukin34 mRNA expression and infiltrating immune cell composition in intrinsic breast cancer subtypes |
|
https://doi.org/10.18632/oncotarget.25226
Karin Zins, Gerwin Heller, Mathias Mayerhofer, Martin Schreiber, and Dietmar Abraham
|
| 23126-23148 |
|
| SB202190 inhibits endothelial cell apoptosis via induction of autophagy and heme oxygenase1 |
|
https://doi.org/10.18632/oncotarget.25234
Margit Schwartz, Sabine Böckmann, Philipp Borchert, and Burkhard Hinz
|
| 23149-23163 |
|
| Preoperative tumor size is associated with deep myometrial invasion and lymph node metastases and is a negative prognostic indicator for patients with endometrial carcinoma |
|
https://doi.org/10.18632/oncotarget.25248
Kohei Nakamura, Kentaro Nakayama, Noriyoshi Ishikawa, Toshiko Minamoto, Tomoka Ishibashi, Kaori Ohnishi, Hitomi Yamashita, Ruriko Ono, Hiroki Sasamori, Sultana Razia, Mohammad Mahmud Hossain, Shanta Kamrunnahar, Masako Ishikawa, and Satoru Kyo
|
| 23164-23172 |
|
| Gene expression profiling in prognosis of distant recurrence in HRpositive and HER2negative breast cancer patients |
|
https://doi.org/10.18632/oncotarget.25258
Tzu-Ting Huang, Nicolas Pennarun, Yu-Hao Cheng, Cheng-Fang Horng, Jason Lei, and Skye Hung-Chun Cheng
|
| 23173-23182 |
|
| RPGR protein complex regulates proteasome activity and mediates storeoperated calcium entry |
|
https://doi.org/10.18632/oncotarget.25259
Sarita Rani Patnaik, Xun Zhang, Lincoln Biswas, Saeed Akhtar, Xinzhi Zhou, Deva Krupakar Kusuluri, James Reilly, Helen May-Simera, Susan Chalmers, John McCarron, and Xinhua Shu
|
| 23183-23197 |
|
| DGCspecific RHOA mutations maintained cancer cell survival and promoted cell migration via ROCK inactivation |
|
https://doi.org/10.18632/oncotarget.25269
Takashi Nishizawa, Kiyotaka Nakano, Aya Harada, Miwako Kakiuchi, Shin-Ichi Funahashi, Masami Suzuki, Shumpei Ishikawa, and Hiroyuki Aburatani
|
| 23198-23207 |
|
| PKD1 is a potential biomarker and therapeutic target in triplenegative breast cancer |
|
https://doi.org/10.18632/oncotarget.25292
Caroline Spasojevic, Elisabetta Marangoni, Sophie Vacher, Franck Assayag, Didier Meseure, Sophie Château-Joubert, Martine Humbert, Manale Karam, Jean Marc Ricort, Christian Auclair, Marie Regairaz, and Ivan Bièche
|
| 23208-23219 |
|
| MAP4K4 controlled integrin β1 activation and cMet endocytosis are associated with invasive behavior of medulloblastoma cells |
|
https://doi.org/10.18632/oncotarget.25294
Dimitra Tripolitsioti, Karthiga Santhana Kumar, Anuja Neve, Jessica Migliavacca, Charles Capdeville, Elisabeth J. Rushing, Min Ma, Noriyuki Kijima, Ashish Sharma, Martin Pruschy, Scott McComb, Michael D. Taylor, Michael A. Grotzer, and Martin Baumgartner
|
| 23220-23236 |
|
| Chloride intracellular channel 1 as a switch among tumor behaviors in human esophageal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.25296
Toshiyuki Kobayashi, Atsushi Shiozaki, Yoshito Nako, Daisuke Ichikawa, Toshiyuki Kosuga, Katsutoshi Shoda, Tomohiro Arita, Hirotaka Konishi, Shuhei Komatsu, Takeshi Kubota, Hitoshi Fujiwara, Kazuma Okamoto, Mitsuo Kishimoto, Eiichi Konishi, Yoshinori Marunaka, and Eigo Otsuji
|
| 23237-23252 |
|
| miR34a miR424 and miR513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation |
|
https://doi.org/10.18632/oncotarget.25298
Peixin Dong, Ying Xiong, Junming Yue, Sharon J.B. Hanley, and Hidemichi Watari
|
| 23253-23263 |
|
| Cytokeratin 8/18 protects breast cancer cell lines from TRAILinduced apoptosis |
|
https://doi.org/10.18632/oncotarget.25297
William P. Bozza, Yaqin Zhang, and Baolin Zhang
|
| 23264-23273 |
|
| The effects of restricted glycolysis on stemcell like characteristics of breast cancer cells |
|
https://doi.org/10.18632/oncotarget.25299
Arindam Banerjee, Pardis Arvinrad, Matthew Darley, Stéphanie A. Laversin, Rachel Parker, Matthew J.J. Rose-Zerilli, Paul A. Townsend, Ramsey I. Cutress, Stephen A. Beers, Franchesca D. Houghton, Charles N. Birts, and Jeremy P. Blaydes
|
| 23274-23288 |
|
| Treatment of ovarian cancer by targeting the tumor stem cellassociated carbohydrate antigen SialylThomsennouveau |
|
https://doi.org/10.18632/oncotarget.25289
Kristen Starbuck, Linah Al-Alem, David A. Eavarone, Silvia Fatima Hernandez, Chiara Bellio, Jillian M. Prendergast, Jenna Stein, Daniel T. Dransfield, Bianca Zarrella, Whitfield B. Growdon, Jeff Behrens, Rosemary Foster, and Bo R. Rueda
|
| 23289-23305 |
|
| Cancer stem cells of hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.24623
Kewei Wang, and Dianjun Sun
|
| 23306-23314 |
|
| A case of ALKrearranged non–small cell lung cancer that responded to ceritinib after development of resistance to alectinib |
|
https://doi.org/10.18632/oncotarget.25143
Yosuke Makuuchi, Hidetoshi Hayashi, Koji Haratani, Junko Tanizaki, Kaoru Tanaka, Masayuki Takeda, Kazuko Sakai, Shigeki Shimizu, Akihiko Ito, Kazuto Nishio, and Kazuhiko Nakagawa
|
| 23315-23319 |
